pet peeve: "GLP-1" is not a category name
GLP-1 agonist means an agonist at the GLP-1 receptor. Semaglutide is one.
Tirzepatide is a dual GLP-1/GIP agonist. Retatrutide is a triple. Calling those "GLP-1s" is like calling every antibiotic penicillin.
It matters because the differences between them are exactly the receptor differences, so a label that erases those makes the comparisons incoherent.
I don't expect to win this one, the usage is entrenched. But if a summary calls everything a GLP-1 that's a decent signal about how carefully the rest was written.